Results 111 to 120 of about 25,215 (206)

Epidemiology of extrapulmonary tuberculosis, Alameda County, California, 2010-2021. [PDF]

J Clin Tuberc Other Mycobact Dis
Nasir S, Marusinec R, Chitnis AS, Jaganath D.   +3 more
europepmc   +1 more source

Acetylator status-guided rapid reintroduction of isoniazid in tuberculosis patients with drug-induced hepatotoxicity. [PDF]

J Clin Tuberc Other Mycobact Dis
van Arkel C, Stemkens R, Magis-Escurra C, Hoefsloot W, Carpaij N, van Ingen J, van Crevel R, van Laarhoven A, Aarnoutse R.   +8 more
europepmc   +1 more source

Utility of Patch Testing, LTT, and HLA Genotyping in Identifying Culprit Drugs and Diagnosing Multiple Drug Hypersensitivity in Definite DRESS: A 10-Year Cohort Study. [PDF]

Clin Transl Allergy
Ünal D, Yeğit OO, Demir S, Erden B, Korkmaz P, Oğuz FS, Çınar ÇK, Temurhan S, Karabacak DE, Toprak ID, Kılınç Z, Yordam MS, Kahveci N, İğde MH, Kamacı ŞÇ, Aslan AF, Sezgin ME, Kaya E, Bölek L, Coşkun R, Olgaç M, Öztop N, Gelincik A.   +22 more
europepmc   +1 more source

Implementing shorter all-oral treatment durations for multidrug-resistant tuberculosis in the UK: from concept to application. [PDF]

BMJ Open Respir Res
Chavda A, Gilchrist M, Capstick T, Chen C, Kon OM.   +4 more
europepmc   +1 more source

Prevalence, Transmission and Genetic Diversity of Pyrazinamide Resistance Among Multidrug-Resistant Mycobacterium tuberculosis Isolates in Hunan, China

Binbin Liu,1,* Pan Su,1,* Peilei Hu,1,* Mi Yan,1 Wenbin Li,1 Songlin Yi,1 Zhenhua Chen,1 Xiaoping Zhang,1 Jingwei Guo,1 Xiaojie Wan,1 Jue Wang,1 Daofang Gong,1 Hua Bai,1 Kanglin Wan,2 Haican Liu,2 Guilian Li,2 Yunhong Tan1 1Clinical ...
Yan M, Liu H, Li G, Yi S, Wan X, Wang J, Li W, Gong D, Guo J, Su P, Chen Z, Zhang X, Tan Y, Wan K, Liu B, Bai H, Hu P   +16 more
core  

Pharmacokinetic modelling as a tool to assess TB treatment adherence: application to the REMEMBER study. [PDF]

IJTLD Open
Abdelgawad N, Chirehwa M, McIlleron H, Kanyama C, Mwelase N, Naidoo A, Kumwenda J, Nyirenda M, Samaneka WP, Lama JR, Mohapi L, Mave V, Veloso VG, Valencia J, Gupta A, Hosseinipour MC, Scarsi K, Denti P.   +17 more
europepmc   +1 more source

A scoping review of interventions in childhood tuberculosis prevention and treatment. [PDF]

Public Health Pract (Oxf)
Rahaman MZ, Alam T, Nahar SS, Nahrin R, Bushra IJ, Ahmed S, Banu S, Shahrin L.   +7 more
europepmc   +1 more source

Tuberculose resistente: revisão molecular

Revista de Saúde Pública
O progresso na compreensão dos mecanismos de resistência aos fármacos usados no tratamento da tuberculose tem permitido o desenvolvimento de novos métodos para a detecção da tuberculose resistente.
Maria Lúcia Rosa Rossetti, Andréia Rosane de Moura Valim, Márcia Susana Nunes Silva, Vívian Sumnienski Rodrigues   +3 more
doaj  

Correction: Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure. [PDF]

PLoS One
Jayanti RP, Cho YS, Soedarsono S, Kim HJ, Kang J, Kim J, Oh JY, Kang BH, Ha JH, Kim JW, Mertaniasih NM, Kusmiati T, Permatasari A, Yuliwulandari R, Kim R, Seong HJ, Ghim JL, Kim DH, Shin JG, cPMTb.   +19 more
europepmc   +1 more source

Population pharmacokinetics of pyrazinamide and ethambutol in children with tuberculosis with or without HIV. [PDF]

Antimicrob Agents Chemother
Maranchick NF, Martyn-Dickens C, Enimil A, Yang H, Amissah AK, Dompreh A, Bosomtwe D, Sly-Moore E, Opoku T, Frimpong Appiah A, Asiedu P, Antwi S, Scheetz MH, Peloquin CA, Kwara A.   +14 more
europepmc   +1 more source